About this trial
This study looks at how to evaluate patients who might join experimental cancer treatment programs at the National Cancer Institute Surgery Branch. Doctors will screen patients by reviewing tests and scans to see if they qualify for these special programs. Patients must be 18 or older and suspected of having cancer. The main goal is to find suitable candidates for ongoing research.
The trial's ID number is NCT00001823. It is not focused on a specific drug or device. The trial hopes to include up to 7,000 patients in total.
Who can join
This trial is open to men and women who are at least 18 years old. They should be suspected of having cancer or have a confirmed cancer diagnosis. Participants must be able to understand and sign a consent form. Women who are pregnant or planning to become pregnant cannot join due to possible risks from some tests. The trial team will confirm who qualifies.
Conditions
Synovial Cell Cancer, Melanoma, Colorectal Cancer, Lung Cancer, Bladder Cancer
Age group
Adult, Older adult
The study team makes the final call on eligibility.
What happens in the study
Participants will undergo various tests and evaluations to see if they can take part in NCI-SB treatment programs. Everyone will be part of a group that includes patients suspected of having cancer. Doctors will assess their eligibility based on the results of these tests over a long period of time.
Where
This trial is running at 1 location in the United States. It is currently recruiting.
National Institutes of Health Clinical Center
Bethesda, Maryland